• Nordic Capital acquires Advanz Pharma for $846m pharmaceutical-technology
    June 03, 2021
    Nordic Capital subsidiary Cidron Aida Bidco has acquired all issued and to-be-issued limited voting share capital of UK-based speciality pharmaceutical company, Advanz Pharma, for a total value of nearly $846m.
PharmaSources Customer Service